Perspectives from Gain Therapeutics
  • All Blogs
  • All Stories
  • About Us
  • Science & Technology
  • Pipeline
  • Investors & Media
  • Contact Us
  • Sign Up
Lead Program in GBA-Parkinson’s Disease

Lead Program in GBA-Parkinson’s Disease

Share

Download: Lead Program in GBA-Parkinson’s Disease 


Share

Related Posts

  • Gain Therapeutics presents at the Jefferies Conference 2022
  • Gain Therapeutics presents at the Jefferies Conference 2022
  • What is Gain Therapeutics Presenting at the MJFF 2021 Parkinson’s Disease Therapeutics Conference Webinar?
  • MJFF 2021 Conference
  • Gain Therapeutics’ Small Molecule Approach for CNS diseases
  • Gain Therapeutics’ Small Molecule Approach for CNS diseases
  • Gain Therapeutics announces issuance of two new pct patents covering gba and galc modulator
  • Gain Therapeutics announces issuance of two new pct patents covering gba and galc modulator
  • When is Parkinson’s Awareness Month and Day?
  • When is Parkinson’s Awareness Month and Day?

Latest Posts

  • Virtual Fireside Chat: Computational Biology in Drug Discovery with Gain Therapeutics (GANX) CTO & Two Experts on Wednesday, March 29th at 12:00 p.m. EDT
  • SUMMARY: Computational Drug Discovery With Gain Therapeutics CEO Matthias Alder
  • SEE-Tx® Platform
  • Lead Program in GBA-Parkinson’s Disease
  • Conversations with Roshan Ahmed : Associate Director of Business Development at Gain Therapeutics
Gain Therapeutics Logo for Dark BG

©2022 Gain Therapeutics, Inc

  • All Blogs
  • All Stories
  • About Us
  • Science & Technology
  • Pipeline
  • Investors & Media
  • Contact Us
  • Sign Up
Menu
  • All Blogs
  • All Stories
  • About Us
  • Science & Technology
  • Pipeline
  • Investors & Media
  • Contact Us
  • Sign Up
Cookie Policy
Privacy Policy

Follow Us

Twitter Linkedin
  • All Blogs
  • All Stories
  • About Us
  • Science & Technology
  • Pipeline
  • Investors & Media
  • Contact Us
  • Sign Up